Localized scleroderma and systemic sclerosis: Is there a connection?

Best Practice and Research: Clinical Rheumatology

Volumn 21, Issue 6, 2007, Pages 1025-1036

  Gupta, Rajnish A ^a   Fiorentino, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

juvenile localized scleroderma; localized scleroderma; morphea; systemic sclerosis; tissue fibrosis

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; DNA ANTIBODY; HISTONE ANTIBODY; ORGANIC SOLVENT; SCL 70 ANTIBODY; SINGLE STRANDED DNA; TUMOR NECROSIS FACTOR ALPHA;

CELL DAMAGE; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; FIBROBLAST; GENETIC RISK; HEREDITY; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; PATHOGENESIS; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; RISK FACTOR; SCLERODERMA; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; SKIN FIBROSIS; SKIN MANIFESTATION; SYSTEMIC DISEASE; SYSTEMIC SCLEROSIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNITY, CELLULAR; MORBIDITY; RISK FACTORS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; WORLD HEALTH;

EID: 36649010808     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2007.09.003     Document Type: Review

References (43)

1. Mayes M.D. Epidemiology of systemic sclerosis and related diseases. Current Opinion in Rheumatology 9 6 (1997) 557-561
2. Valentini G., and Black C. Systemic sclerosis. Best Practice and Research. Clinical Rheumatology 16 5 (2002) 807-816
3. Steen V.D., Oddis C.V., Conte C.G., et al. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis and Rheumatism 40 3 (1997) 441-445
4. Peterson L.S., Nelson A.M., Su W.P., et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. The Journal of Rheumatology 24 1 (1997) 73-80
5. Arnett F.C., Cho M., Chatterjee S., et al. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis and Rheumatism 44 6 (2001) 1359-1362
6. Feghali-Bostwick C., Medsger Jr. T.A., and Wright T.M. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis and Rheumatism 48 7 (2003) 1956-1963
7. Sato H., Lagan A.L., Alexopoulou C., et al. The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. Arthritis and Rheumatism 50 2 (2004) 558-564
8. Assassi S., and Tan F.K. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays. Current Opinion in Rheumatology 17 6 (2005) 761-767
9. Nelson J.L., Furst D.E., Maloney S., et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351 9102 (1998) 559-562
10. Iranzo P., Lopez I., Palou J., et al. Morphoea in three siblings. Journal of the European Academy of Dermatology and Venereology 15 1 (2001) 46-47
11. Patrizi A., Marzaduri S., and Marini R. A familial case of scleroderma en coup de sabre. Acta Dermato-Venereologica 80 3 (2000) 237
12. Ferri C., Zakrzewska K., Longombardo G., et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clinical and Experimental Rheumatology 17 6 (1999) 718-720
13. Lunardi C., Bason C., Navone R., et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Natural Medicines 6 10 (2000) 1183-1186
14. Nietert P.J., and Silver R.M. Systemic sclerosis: environmental and occupational risk factors. Current Opinion in Rheumatology 12 6 (2000) 520-526
15. Weide B., Walz T., and Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. British Journal of Dermatology 142 4 (2000) 636-644
16. Tuffanelli D.L. Localized scleroderma. Seminars in Cutaneous Medicine and Surgery 17 1 (1998) 27-33
17. Chung L., Lin J., Furst D.E., et al. Systemic and localized scleroderma. Clinics in Dermatology 24 5 (2006) 374-392
18. Zulian F. Systemic manifestations in localized scleroderma. Current Rheumatology Reports 6 6 (2004) 417-424
19. Dehen L., Roujeau J.C., Cosnes A., et al. Internal involvement in localized scleroderma. Medicine (Baltimore) 73 5 (1994) 241-245
20. Zulian F., Vallongo C., Woo P., et al. Localized scleroderma in childhood is not just a skin disease. Arthritis and Rheumatism 52 9 (2005) 2873-2881
21. Varga J., and Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. The Journal of Clinical Investigation 117 3 (2007) 557-567
22. Kahaleh M.B., Sherer G.K., and LeRoy E.C. Endothelial injury in scleroderma. The Journal of Experimental Medicine 149 6 (1979) 1326-1335
23. Kahaleh M.B. Raynaud phenomenon and the vascular disease in scleroderma. Current Opinion in Rheumatology 16 6 (2004) 718-722
24. Sgonc R., Gruschwitz M.S., Dietrich H., et al. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. The Journal of Clinical Investigation 98 3 (1996) 785-792
25. Helmbold P., Fiedler E., Fischer M., et al. Hyperplasia of dermal microvascular pericytes in scleroderma. Journal of Cutaneous Pathology 31 6 (2004) 431-440
26. Artlett C.M. Immunology of systemic sclerosis. Frontiers in Bioscience 10 (2005) 1707-1719
27. Ihn H., Yazawa N., Kubo M., et al. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease. The Journal of Rheumatology 27 3 (2000) 698-702
28. Hu P.Q., Fertig N., Medsger Jr. T.A., et al. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis and Rheumatism 48 5 (2003) 1363-1373
29. Cepeda E.J., and Reveille J.D. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Current Opinion in Rheumatology 16 6 (2004) 723-732
30. Falanga V., Medsger Jr. T.A., Reichlin M., et al. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Annals of Internal Medicine 104 6 (1986) 849-857
31. Sato S., Fujimoto M., Ihn H., et al. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. Journal of the American Academy of Dermatology 31 4 (1994) 567-571
32. Takehara K., and Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology (Oxford) 44 3 (2005) 274-279
33. Baroni S.S., Santillo M., Bevilacqua F., et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. The New England Journal of Medicine 354 25 (2006) 2667-2676
34. Falanga V., Medsger T.A., and Reichlin M. High titers of antibodies to single-stranded DNA in linear scleroderma. Archives of Dermatology 121 3 (1985) 345-347
35. Hayakawa I., Hasegawa M., Takehara K., et al. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. Arthritis and Rheumatism 50 1 (2004) 227-232
36. Sato S., Ihn H., Soma Y., et al. Antihistone antibodies in patients with localized scleroderma. Arthritis and Rheumatism 36 8 (1993) 1137-1141
37. Pannu J., and Trojanowska M. Recent advances in fibroblast signaling and biology in scleroderma. Current Opinion in Rheumatology 16 6 (2004) 739-745
38. Ihn H., Yamane K., Kubo M., et al. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors. Arthritis and Rheumatism 44 2 (2001) 474-480
39. Kubo M., Ihn H., Yamane K., et al. Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis and Rheumatism 44 3 (2001) 731-734
40. Asano Y., Ihn H., Jinnin M., et al. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma. The Journal of Investigative Dermatology 126 8 (2006) 1761-1769
41. Zhou L., Askew D., Wu C., et al. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. The Journal of Investigative Dermatology 127 2 (2007) 281-292
42. Whitfield M.L., Finlay D.R., Murray J.I., et al. Systemic and cell type-specific gene expression patterns in scleroderma skin. Proceedings of the National Academy of Sciences of the United States of America 100 21 (2003) 12319-12324
43. Tan F.K., Hildebrand B.A., Lester M.S., et al. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis and Rheumatism 52 3 (2005) 865-876